newsfilter
← Latest News
GlobeNewswire·

Prometheus Biosciences to Present at the SVB Securities Global Biopharma Conference

SAN DIEGO, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Prometheus Biosciences, Inc. (NASDAQ:RXDX), a clinical-stage biotechnology company pioneering a precision medicine approach for the discovery, development, and